Maharashtra, India

Sunanda Phadtare

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Generics (UK) Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sunanda Phadtare. Retrieved from https://idiyas.com/inventor/sunanda-phadtare

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sunanda Phadtare: Innovator in Pharmaceutical Chemistry

Introduction

Sunanda Phadtare is a notable inventor based in Maharashtra, India. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel crystalline forms of bosentan. Her work is crucial for advancing treatments for various cardiovascular disorders.

Latest Patents

Sunanda holds 1 patent for her invention titled "Crystalline forms of bosentan." This invention relates to novel crystalline forms of bosentan and the processes for their preparation. Furthermore, it encompasses pharmaceutical compositions that include these crystalline forms and their application in treating patients suffering from endothelin receptor-mediated disorders, such as hypertension, pulmonary hypertension, ischemia, vasospasm, and angina pectoris.

Career Highlights

Sunanda Phadtare is currently associated with Generics (UK) Limited, where she continues to innovate in the pharmaceutical sector. Her expertise in the field has positioned her as a valuable asset to her organization and the industry at large.

Collaborations

Some of her notable coworkers include Abhay Gaitonde and Bindu Manojkumar, who contribute to her research and development efforts.

Conclusion

Sunanda Phadtare's work in pharmaceutical chemistry exemplifies the impact of innovation on healthcare. Her contributions are paving the way for improved treatments for cardiovascular disorders, showcasing the importance of research and development in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…